The 2005 Italian quality control study for the evaluation of CD4 cells in centers involved in the treatment of HIV type 1 patients

AIDS Research and Human Retroviruses

Volumn 23, Issue 6, 2007, Pages 777-781

  Martini, Federico ^a   D'Offizi, Gianpiero ^a   Girardi, Enrico ^a   Vitale, Alessia ^a   Cimini, Eleonora ^a   Mollicone, Bianca ^b   Vlassi, Crysoula ^a   Aiuti, Fernando ^b   Atripaldi, L ^c   Bodini, U ^d   De Francesco, D ^e   De Soccio, G ^f   Gallo, L ^g   Gentileschi, E ^h   Giudizi, M G ⁱ   Martini, C ^j   Mordacchini, M ^k   Moroni, G A ^l   Pagliaro, P P ^m   Piras, S ⁿ   Soldini, L ^o   Vanacore, R ^p   Vullo, V ^q   more..

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^d CREMONA HOSPITAL   (Italy)

^e BUSTO ARSIZIO HOSPITAL   (Italy)

^f SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

^j MARIA VITTORIA HOSPITAL   (Italy)

^k OSPEDALE CA FONCELLO   (Italy)

^l AOS Paolo   (Italy)

^m CARLO POMA HOSPITAL   (Italy)

ⁿ SS Trinit Hospital   (Italy)

^o Centro San Luigi   (Italy)

^p UNIVERSITY HOSPITAL OF PISA   (Italy)

^q POLICLINICO UMBERTO I   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; REPRODUCIBILITY;

CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; ITALY; LABORATORIES, HOSPITAL; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS;

EID: 34447289386     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0295     Document Type: Article

References (23)

1. Fahey JL, Taylor JM, Detels R, et al.: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990;322:166-172.
2. Centers for Disease Control: Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
3. Centers for Disease Control: Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation. MMWR Recomm Rep 1998;47:43-82.
4. Mandigo K, Raboud JM, Haley L, and Montaner JS: Variability in leukocyte subset measurements among five laboratories in Vancouver. Clin Invest Med 1995;18:349-356.
5. Schwartz A and Fernandez-Repollet E: Development of clinical standards for flow cytometry. Ann NY Acad Sci 1993;677:28-39.
6. Brando B and Sommaruga E: Nationwide quality control trial on lymphocyte immunophenotyping and flow cytometer performance in Italy. Cytometry 1993;14:294-306.
7. Peddecord KM, Benenson AS, Hofherr LK, et al.: Variability of reporting and lack of adherence to consensus guidelines in human T-lymphocyte immunophenotyping reports: Results of a case series. J Acquir Immune Defic Syndr 1993;6:823-830.
8. Centers for Disease Control: 1997 revised guidelines for performing CD4+ T-cell determination in persons infected with human immunodeficiency virus (HIV). MMWR 1997;46:1-29.
9. Centers for Disease Control: Centers for Disease Control and Prevention Model Performance Evaluation Program: T-lymphocyte immunophenotyping (CD4+ T-cell detrminations): Report or results for the Performance Evaluation Survey conducted in October 2002. www.phppacdc.gov/mpep/pdf/tli/0210cd4.pdf
10. Centers for Disease Control: Guidelines for performing single-platform absolute CD4+ T-cell determination with CD45 gating in persons infected with human immunodeficiency virus (HIV). MMWR 2003;52:1-14.
11. Bergeron M, Faucher S, Minkus T, et al.: Impact of unified procedures as implemented in the Canadian Quality Assurance Program for T lymphocyte subset enumeration. Participating Flow Cytometry Laboratories of the Canadian Clinical Trials Network for HIV/AIDS Therapies. Cytometry 1998;33:146-155.
12. Gelman R, Cheng SC, Kidd P, Waxdal M, and Kagan J: Assessment of the effects of instrumentation, monoclonal antibody, and fluorochrome on flow cytometric immunophenotyping: A report based on 2 years of the NIAID DAIDS flow cytometry quality assessment program. Clin Immunol Immunopathol 1993;66:150-162.
13. Giorgi JV, Cheng HL, Margolick JB, et al.: Quality control in the flow cytometric measurement of T-lymphocyte subsets: The multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group. Clin Immunol Immunopathol 1990;55:173-186.
14. Gratama JW, Kraun J, Van den BR, et al.: Analysis of variation in results of flow cytometric lymphocyte immunophenotyping in a multicenter study. Cytometry 1997;30:166-177.
15. Homburger HA, Rosenslock W, Paxton H, Paton ML, and Landay AL: Assessment of interlaboratory variability of immunophenotyping. Results of the College of American Pathologists Flow Cytometry Survey. Ann NY Acad Sci 1993;677:43-49.
16. Kagan J, Gelman R, Waxdal M, and Kidd P: NIAID Division of AIDS flow cytometry quality assessment program. Ann NY Acad Sci 1993;677:50-52.
17. Mandy F, Bergeron M, Houle G, Bradley J, and Fahey J: Impact of the international program for Quality Assessment and Standardization for Immunological Measures Relevant to HIV/AIDS: QASI. Cytometry 2002;50:111-116.
18. Vesely R, Barths J, Vanlangendonck F, Hannet I, and Strauss K: Initial results of Central European Immunophenotyping Quality Control Program (CEQUAL). Cytometry 1996;26:108-112.
19. Whitby L, Granger V, Storie I, et al.: Quality control of CD4+ T-lymphocyte enumeration: Results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for Immune Monitoring (1993-2001). Cytometry 2002;50:102-110.
20. Zenger VE, Vogt R, Mandy F, Schwartz A, and Marti GE: Quantitative flow cytometry: Inter-laboratory variation. Cytometry 1998;33:138-145.
21. Paxton H, Kidd P, Landay A, et al.: Results of the flow cytometry ACTG quality control program: Analysis and findings. Clin Immunol Immunopathol 1989;52:68-84.
22. Pandolfi F, Alario C, Girardi E, et al.: The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group. Clin Exp Immunol 1998;111:564-573.
23. Bergeron M, Shafaie A, Ding T, et al.: Evaluation of stabilized blood cell products as candidate preparations for quality assessment programs for CD4 T-cell counting. Cytometry 2002;50: 86-91.